Pfizer Loses Legal Bid to Temporarily Block Novo’s Metsera Offer

A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

Delaware Chancery Judge Morgan Zurn concluded Wednesday that Pfizer didn’t level legitimate complaints about Novo’s effort to supplant it as New York-based Metsera’s buyer and refused to bar the Danish company from proceeding with the transaction.